House GOP reps question FDA commissioner on drugs with China-only data, trial site inspections
Regulatory NewsJeff Craven
AsiaAudit/inspectionBiologics/ biosimilars/ vaccinesClinical TrialsNorth AmericaPharmaceuticalsRegulatory NewsJeff CravenAsiaAudit/inspectionBiologics/ biosimilars/ vaccinesClinical TrialsNorth AmericaPharmaceuticals